DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer
Translational Research · 2024-10 · 272 · 126-139
DOI: 10.1016/j.trsl.2024.05.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2024-10. Verfasst von Ming Dong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, No.639, Zhi Zaoju Road, …. Hauptthemen laut MEDLINE: Chemokine CXCL10, Ovarian Neoplasms, Dendritic Cells, T-Lymphocytes, Cytotoxic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
This study investigates the role of dendritic cells (DCs), with a focus on their CXCL10 marker gene, in the activation of cytotoxic T lymphocytes (CTLs) within the ovarian cancer microenvironment and its impact on disease progression. Utilizing scRNA-seq data and immune infiltration analysis, we identified a diminished DC presence in ovarian cancer. Gene analysis pinpointed CXCL10 as a key regulator in OV progression via its influence on DCs and CTLs. Prognostic analysis and in vitro experiments substantiated this role. Our findings reveal that DC-derived CXCL10 significantly affects CTL activation and proliferation. Reduced CXCL10 levels hinder CTL cytotoxicity, promoting ovarian cancer cell migration and invasion. Experimental studies using animal models have provided further evidence that the capacity of CTLs to suppress tumor development is significantly diminished when treated with DCs that have low expression of CXCL10. Dendritic cell-derived CXCL10 emerges as a pivotal factor in restraining ovarian cancer growth and metastasis through the activation of cytotoxic T lymphocytes. This study sheds light on the crucial interplay within the ovarian cancer microenvironment, offering potential therapeutic targets for ovarian cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, No.639, Zhi Zaoju Road, Huangpu District, Shanghai 200011, PR China.
- Department of Obstetrics and Gynecology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, No.639, Zhi Zaoju Road, Huangpu District, Shanghai 200011, PR China. Electronic address: 11908…
Förderung
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Dong, M., Lu, L., Xu, H., & Ruan, Z. (2024). DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer. Translational Research, 272, 126-139. https://doi.org/10.1016/j.trsl.2024.05.013
Vancouver
Dong M, Lu L, Xu H, Ruan Z. DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer. Translational Research. 2024;272:126-139. doi:10.1016/j.trsl.2024.05.013
BibTeX
@article{Dong2024,
author = {Dong, Ming and Lu, Lili and Xu, Hui and Ruan, Zhengyi},
title = {DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer},
journal = {Translational Research},
year = {2024},
volume = {272},
pages = {126--139},
doi = {10.1016/j.trsl.2024.05.013}
}
EUVIMED